3 U.S. Stocks With Domestic Supply Chains as Tariffs Reshape Investor Focus

With fresh tariffs on 60 key U.S. trading partners drawing a hard line on forced labor, the spotlight has swung to companies that rely more on domestic supply chains than global ones. This shift could reshape where risks and potential opportunities sit in your portfolio, especially as costs and inflation pressures ripple through. This article walks through three U.S.-focused stocks exposed to the tariff story and explains why they may warrant closer attention now.

The three stocks covered below are only a starting sample, and the full screen surfaced 92 more U.S. focused companies with equally compelling supply chain stories that are not included here. To go deeper into this theme, head straight to the U.S. Domestic Supply Chain Stocks screener to identify, filter, and analyze the domestic operators that best fit your own risk and return preferences.

Encompass Health (EHC)

Overview: Encompass Health is a post-acute healthcare company that runs inpatient rehabilitation hospitals across the U.S. and Puerto Rico, helping patients recover functional ability and independence after serious events such as strokes, neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic issues, and amputations, with most revenue coming from Medicare and other insurers.

Market Cap: US$12.35b

Encompass Health gives investors direct exposure to U.S. inpatient rehabilitation at a time when tariffs are pushing capital toward domestically anchored business models. The company is adding hospitals and beds to address demand from an aging population, and it is investing in AI tools intended to improve clinical workflows and support margins. Reported results include higher occupancy and discharges, updated 2026 guidance, and ongoing dividends and buybacks that return capital to shareholders. Key risks include meaningful debt, heavy construction spending, and continued dependence on Medicare and other government payers. For investors who are comfortable with those risks, the combination of growth projects, U.S.-focused supply chain, and a defined capital return program may warrant closer consideration of Encompass Health.

Encompass Health’s expanding hospital footprint and AI push suggest there is more behind its U.S. growth story than tariffs alone. Start with the 3 key rewards and 1 important warning sign to see what could tilt the balance next.

Build your own U.S. healthcare and services shortlist

Encompass Health and the two other stocks in this piece all came from a single Simply Wall St screen, but the real edge comes when you shape the filters yourself. Use our flexible Screener to mix valuation, growth, balance sheet and risk metrics, or start with any of our curated Investing Ideas.

Molina Healthcare (MOH)

Overview: Molina Healthcare is a U.S. health insurer that arranges and pays for medical care for low income individuals and families, mainly through Medicaid, Medicare, and Affordable Care Act marketplace plans operated in partnership with state and federal programs.

Operations: Molina Healthcare generates nearly all of its US$42.5b in revenue in the United States, led by Medicaid at about US$32.1b, Medicare at US$6.2b, Marketplace plans at US$3.6b and smaller contributions from other services.

Market Cap: US$10.23b

Molina Healthcare gives you exposure to a tariff resilient, purely domestic healthcare model that leans on U.S. providers rather than global supply chains, which can matter when import costs and inflation pick up. The company is tightly tied to government programs where contract wins, Medicaid rate decisions and cost control can shift earnings power quickly in either direction. Analysts currently see earnings growth potential and a path from losses to profitability, and the stock trades at a low P/S multiple and a discount to some cash flow based estimates. That mix of policy risk, balance sheet leverage and discounted valuation makes Molina Healthcare a stock some investors may choose to watch more closely.

Molina Healthcare’s discounted P/S and tight link to U.S. government programs suggest that the stock’s story may be more about mispriced earnings power than headline risk. Scan the 3 key rewards and 1 important warning sign to see what the market might be missing next.

Chefs' Warehouse (CHEF)

Overview: Chefs' Warehouse supplies independent restaurants, hotels, caterers and other premium foodservice customers with specialty ingredients such as artisan cheeses, charcuterie, truffles and chocolate, alongside custom cut beef, seafood, poultry and other core kitchen staples across the U.S., Canada and the Middle East.

Operations: Chefs' Warehouse generates about US$4.39b in revenue from foodservice distribution, with roughly US$4.01b coming from the United States and US$385 million from international markets.

Market Cap: US$4.50b

Chefs' Warehouse sits at the intersection of premium dining, domestic supply chains and rising tariff friction. This is why it stands out in this screener. Management reports that most products are sourced from within the U.S. or via a wide supplier base, so the company has options when tariffs or input costs shift and can often substitute SKUs rather than absorb margin pressure. On the other hand, the stock carries high debt, a rich P/E and recent insider selling, which gives you several factors to weigh up when considering how much room it deserves in a portfolio focused on tariff-resilient operators.

Chefs' Warehouse appears to be a premium growth story that may be masking more risk in its high P/E and debt load than many investors realize. Read the 3 key rewards and 2 important warning signs to see what could change the story next.

Seeking Fresh Alternatives Beyond Tariff Plays

Some stocks move first and fastest when themes shift and those early breakouts can get away quickly. Spot fresh ideas before the crowd catches them and act now.

• Track where quality and value meet by scanning a curated 52 high quality undervalued stocks that could be flying under the radar for now.
• Ride secular trends in automation by reviewing hand picked 37 robotics and automation stocks while the story is still developing and momentum is building.
• Stay ahead of policy shifts in energy by checking focused 89 nuclear energy infrastructure stocks before sentiment swings and prices start moving.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com